Skip to main content
LISATA THERAPEUTICS, INC. logo

LISATA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LSTA ISIN · US1280583022 LEI · 5493002287F62M3EGQ04 US Manufacturing
Open in API
Filings indexed 1,093 across all filing types
Latest filing 2014-06-19 Director's Dealing
Country US United States of America
Listing US LSTA

About LISATA THERAPEUTICS, INC.

https://www.lisata.com/

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2014-06-19 English
S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC by NeoStem, Inc. It is a registration statement under the Securities Act of 1933 for the registration of common stock underlying previously issued warrants. The document includes details about the securities being registered, the offering price, and legal disclaimers typical of SEC registration statements. It is not an annual report, earnings release, or any other financial report but a capital markets filing related to securities registration and offering. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is the actual registration statement, not just an announcement of a report, so it is not RPA or RNS. Confidence is high given the clear identification of the form and content.
2014-06-12 English
OWNERSHIP DOCUMENT
Director's Dealing
2014-06-05 English
424B5
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) and includes detailed information about a common stock offering, including terms, risk factors, use of proceeds, and company business overview. It references a Registration No. and is clearly related to a capital raising event. The document is not a financial report, earnings release, or management discussion but rather a detailed offering document for securities issuance. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and financing activities. The document length and content confirm it is not a brief announcement or a report publication notice but the actual offering document.
2014-06-03 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated June 2, 2014. It discusses the filing of a prospectus supplement related to a shelf registration statement and a common stock purchase agreement. It includes legal opinions and consents as exhibits. The document is short (3215 characters) and primarily serves as a regulatory announcement of other filings and legal opinions rather than containing substantive financial data or detailed financial reports. It does not contain financial statements or detailed management discussion. Therefore, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2014-06-03 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated May 29, 2014. It announces a press release regarding clinical trial results for an investigational therapy. The document does not contain financial statements or detailed financial data but rather a disclosure of a press release. The length is 4223 characters, which is relatively short and the document states that the press release is attached as Exhibit 99.1. This fits the pattern of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into other specific categories such as earnings release or annual report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2014-05-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.